Barbara Dozza
Overview
Explore the profile of Barbara Dozza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cevolani L, Focaccia M, Spazzoli B, Bruschi A, Staals E, Dozza B, et al.
J Hip Preserv Surg
. 2025 Jan;
11(4):263-270.
PMID: 39839553
The aim of this article is to determine the safety and efficacy of core decompression (CD) combined with injection of autologous bone marrow concentrate (BMC), demineralized bone matrix (DBM), and...
2.
Aso A, Aiba H, Traversari M, Righi A, Gambarotti M, Atherley OMeally A, et al.
Skeletal Radiol
. 2024 May;
53(12):2653-2664.
PMID: 38713225
Objective: No consensus exists for tumor volume response criteria in patients with Ewing sarcoma. This study aimed to identify an optimal cutoff for predicting a good histological response by analyzing...
3.
Aiba H, Righi A, Spinnato P, Longhi A, Frega G, Atherley OMeally A, et al.
Skeletal Radiol
. 2024 Apr;
53(12):2617-2625.
PMID: 38679636
Objective: To depict histological and imaging features of myoepithelial carcinoma of the bone and soft tissue. Materials And Methods: We retrospectively examined histological features in 22 patients with myoepithelial carcinoma...
4.
Guerrieri A, Bellotti C, Penzo M, Columbaro M, Pannella M, De Vita A, et al.
BMC Cancer
. 2023 Dec;
23(1):1194.
PMID: 38057796
Background: Myxofibrosarcoma is a rare malignant soft tissue sarcoma characterised by multiple local recurrence and can become of higher grade with each recurrence. Consequently, myxofibrosarcoma represents a burden for patients,...
5.
Campanacci L, Cevolani L, Focaccia M, Di Gennaro G, Dozza B, Staals E, et al.
Children (Basel)
. 2023 Nov;
10(11).
PMID: 38002863
The objective of this study was to determine the efficacy of the PRECICE 2 nail in the treatment of lower limb length discrepancy in patients with a history of bone...
6.
Cevolani L, Staals E, Campanacci L, Dozza B, Martella C, Spinnato P, et al.
J Surg Oncol
. 2023 Aug;
128(8):1428-1436.
PMID: 37638388
Introduction: Aneurysmal bone cyst (ABC) is a lytic benign bone lesion representing about 1% of all primary bone tumors. Method to treat ABC's have developed over time. The standard of...
7.
Cevolani L, Campanacci L, Staals E, Dozza B, Bianchi G, Terlizzi F, et al.
J Surg Oncol
. 2023 Mar;
128(1):125-133.
PMID: 36966436
Background: Bone metastases are frequent in patients with cancer. Electrochemotherapy (ECT) is a minimally invasive treatment based on a high-voltage electric pulse combined with an anticancer drug. Preclinical and clinical...
8.
Martella E, Dozza B, Ferroni C, Obeyok C, Guerrini A, Tedesco D, et al.
Pharmaceutics
. 2022 Mar;
14(3).
PMID: 35336051
Osteosarcoma treatment is moving towards more effective combination therapies. Nevertheless, these approaches present distinctive challenges that can complicate the clinical translation, such as increased toxicity and multi-drug resistance. Drug co-encapsulation...
9.
Lenna S, Bellotti C, Duchi S, Martella E, Columbaro M, Dozza B, et al.
J Exp Clin Cancer Res
. 2020 Feb;
39(1):40.
PMID: 32087737
Background: Osteosarcoma (OS) is an aggressive malignant neoplasm that still suffers from poor prognosis in the case of distal metastases or occurrence of multi-drug resistance. It is therefore crucial to...
10.
Pollino S, Palmerini E, Dozza B, Bientinesi E, Piccinni-Leopardi M, Lucarelli E, et al.
J Bone Oncol
. 2019 Jun;
17:100239.
PMID: 31193811
Osteosarcoma (OS) is the most frequent primary malignant tumour of bone and metastases occur in 30% of cases, the 5-year survival rate is 25-30%. Although pre- and post-operative chemotherapy has...